Tandlægeselskabet Godt Smil Holbæk ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 5.2% 1.6% 1.7% 1.3%  
Credit score (0-100)  0 42 74 73 79  
Credit rating  N/A BBB A A A  
Credit limit (kDKK)  0.0 0.0 7.9 4.2 77.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 1,395 7,580 8,604 12,163  
EBITDA  0.0 -329 1,583 1,527 2,526  
EBIT  0.0 -642 831 742 1,792  
Pre-tax profit (PTP)  0.0 -719.2 664.2 599.6 1,679.3  
Net earnings  0.0 -560.2 524.5 473.9 1,316.6  
Pre-tax profit without non-rec. items  0.0 -719 664 600 1,679  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 5,171 4,354 4,039 3,928  
Shareholders equity total  0.0 504 1,028 1,502 1,619  
Interest-bearing liabilities  0.0 2,182 3,572 3,288 2,602  
Balance sheet total (assets)  0.0 6,685 6,223 5,947 5,920  

Net Debt  0.0 1,929 3,013 3,043 2,338  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 1,395 7,580 8,604 12,163  
Gross profit growth  0.0% 0.0% 443.3% 13.5% 41.4%  
Employees  0 2 8 10 14  
Employee growth %  0.0% 0.0% 300.0% 25.0% 40.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 6,685 6,223 5,947 5,920  
Balance sheet change%  0.0% 0.0% -6.9% -4.4% -0.5%  
Added value  0.0 -328.9 1,583.1 1,494.5 2,526.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 4,858 -1,569 -1,099 -845  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 1.0 2.0 3.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% -46.0% 11.0% 8.6% 14.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -9.5% 13.4% 12.7% 30.8%  
ROI %  0.0% -10.9% 16.5% 16.5% 40.6%  
ROE %  0.0% -111.2% 68.5% 37.5% 84.4%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 7.8% 16.9% 26.5% 27.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -586.6% 190.3% 199.3% 92.6%  
Gearing %  0.0% 433.2% 347.5% 218.9% 160.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 7.5% 6.9% 5.1% 5.1%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.2 0.4 0.6 0.5  
Current Ratio  0.0 0.3 0.5 0.7 0.6  
Cash and cash equivalent  0.0 252.2 559.0 245.6 264.2  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -2,102.7 -1,062.5 -589.4 -696.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -164 198 149 180  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 -164 198 153 180  
EBIT / employee  0 -321 104 74 128  
Net earnings / employee  0 -280 66 47 94